Cargando…
Chinese Patent Medicine Shufeng Jiedu Capsules as an Adjuvant Therapy for Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
Background: Shufeng Jiedu (SFJD) capsules can be used as adjunctive treatment for patients with community-acquired pneumonia, but the effectiveness and safety of SFJD are not clear. This review aims to evaluate the effectiveness and safety of SFJD based on randomized controlled trials (RCTs). Method...
Autores principales: | Zhang, Xiao-Wen, Xia, Ru-Yu, Gao, Jia-Qi, Liu, Jin-Jun, Xu, De-Hao, Li, Xun, Hu, Xiao-Yang, Willcox, Merlin, Moore, Michael, Dai, Meng-Yuan, Trill, Jeanne, Fei, Yu-Tong, Liu, Jian-Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289368/ https://www.ncbi.nlm.nih.gov/pubmed/35860018 http://dx.doi.org/10.3389/fphar.2022.923395 |
Ejemplares similares
-
Shufeng Jiedu capsules for treating acute exacerbations of chronic obstructive pulmonary disease: a systematic review and meta-analysis
por: Xia, Ru-yu, et al.
Publicado: (2020) -
Chinese patent herbal medicine (Shufeng Jiedu capsule) for acute upper respiratory tract infections: A systematic review and meta-analysis
por: Zhang, Ying-ying, et al.
Publicado: (2021) -
Investigating the mechanism of ShuFeng JieDu capsule for the treatment of novel Coronavirus pneumonia (COVID-19) based on network pharmacology
por: Chen, Xiao, et al.
Publicado: (2020) -
Shufeng Jiedu capsule for acute exacerbation of chronic obstructive pulmonary disease: a protocol of multicentre, randomised, double-blind, placebo-controlled trial
por: Xia, Ruyu, et al.
Publicado: (2023) -
Study on basic and clinical application of Shufeng Jiedu Capsule in treating respiratory tract infection
por: Han, Yanqi, et al.
Publicado: (2023)